Pulmonary artery denervation - the suspense continues?
作者信息
Mahfoud Felix, Götzinger Felix
机构信息
Department of Internal Medicine III - Cardiology, Angiology, and Internal Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
出版信息
EuroIntervention. 2023 Oct 23;19(8):623-624. doi: 10.4244/EIJ-E-23-00033.
Abstract
摘要
相似文献
1
Pulmonary artery denervation - the suspense continues?肺动脉去神经支配——悬念仍在继续？
EuroIntervention. 2023 Oct 23;19(8):623-624. doi: 10.4244/EIJ-E-23-00033.
2
Pulmonary Artery Denervation: The New Kid on the Block?肺动脉去神经支配：新出现的事物？
J Am Coll Cardiol. 2020 Aug 25;76(8):927-929. doi: 10.1016/j.jacc.2020.06.067.
3
Pulmonary Artery Denervation for Combined Pre- and Post-Capillary Pulmonary Hypertension: Hype or Hope?用于毛细血管前和毛细血管后合并性肺动脉高压的肺动脉去神经支配：炒作还是希望？
JACC Heart Fail. 2023 Aug;11(8 Pt 2):1147-1149. doi: 10.1016/j.jchf.2023.06.015. Epub 2023 Jul 19.
4
Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.在急性猪肺动脉高压模型中，肺动脉去神经支配可降低肺动脉压力并引起组织学改变。
Circ Cardiovasc Interv. 2015 Nov;8(11):e002569. doi: 10.1161/CIRCINTERVENTIONS.115.002569.
5
Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension.针对药物难治性肺动脉高压患者的导管介入治疗。
Circ Cardiovasc Interv. 2015 Nov;8(11):e003332. doi: 10.1161/CIRCINTERVENTIONS.115.003332.
6
Pulmonary artery denervation significantly improves right ventricular longitudinal strain in pulmonary hypertension induced by dehydromonocrotaline.肺动脉去神经支配可显著改善由脱水野百合碱诱导的肺动脉高压中的右心室纵向应变。
Minerva Med. 2024 Feb;115(1):119-120. doi: 10.23736/S0026-4806.22.08259-3. Epub 2022 Jul 5.
7
Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension.通过确定靶向消融部位进行肺动脉去神经支配治疗肺动脉高压
Circ Cardiovasc Interv. 2017 Oct;10(10). doi: 10.1161/CIRCINTERVENTIONS.117.005812.
8
[Pulmonary artery denervation in pulmonary hypertension: physiological and clinical aspects].[肺动脉去神经支配治疗肺动脉高压：生理与临床方面]
Angiol Sosud Khir. 2021;27(3):16-21. doi: 10.33529/ANGIO2021309.
9
Pulmonary Artery Denervation for Pulmonary Artery Hypertension.肺动脉去神经术治疗肺动脉高压
JACC Cardiovasc Interv. 2015 Dec 28;8(15):2024-2025. doi: 10.1016/j.jcin.2015.10.022.
10
[Chinese expert advisory on percutaneous pulmonary artery denervation for the treatment of pulmonary hypertension].[经皮肺动脉去神经术治疗肺动脉高压的中国专家共识]
Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Jun 24;52(6):647-658. doi: 10.3760/cma.j.cn112148-20231230-00545.
本文引用的文献
1
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial.一项针对 1 型肺动脉高压的肺动脉去神经支配的假对照随机临床试验：PADN-CFDA 试验的一年结果。
EuroIntervention. 2023 Oct 23;19(8):684-694. doi: 10.4244/EIJ-D-23-00349.
2
Interventional therapies for pulmonary embolism.肺栓塞的介入治疗。
Nat Rev Cardiol. 2023 Oct;20(10):670-684. doi: 10.1038/s41569-023-00876-0. Epub 2023 May 12.
3
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.肺动脉去神经术治疗肺动脉高压：一项假手术对照、随机的 PADN-CFDA 试验。
JACC Cardiovasc Interv. 2022 Dec 12;15(23):2412-2423. doi: 10.1016/j.jcin.2022.09.013. Epub 2022 Sep 18.
4
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
5
A global view of pulmonary hypertension.肺动脉高压的全球视野。
Lancet Respir Med. 2016 Apr;4(4):306-22. doi: 10.1016/S2213-2600(15)00543-3. Epub 2016 Mar 12.
6
Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.肺动脉去神经支配可减轻脱氢单硝酸异山梨酯诱导肺动脉高压犬的肺动脉重塑。
JACC Cardiovasc Interv. 2015 Dec 28;8(15):2013-2023. doi: 10.1016/j.jcin.2015.09.015.
7
Selexipag for the Treatment of Pulmonary Arterial Hypertension.塞乐西帕用于肺动脉高压的治疗。
N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184.
8
Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).肺动脉去神经术治疗肺动脉高压：单中心、前瞻性、首例人体 PADN-1 研究（首例人体肺动脉去神经术治疗肺动脉高压）。
J Am Coll Cardiol. 2013 Sep 17;62(12):1092-1100. doi: 10.1016/j.jacc.2013.05.075. Epub 2013 Jul 10.
9
Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.经皮肺动脉去神经支配术可完全消除体内实验性肺动脉高压。
EuroIntervention. 2013 Jun 22;9(2):269-76. doi: 10.4244/EIJV9I2A43.
10
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.持续静脉输注依前列醇（前列环素）与常规疗法治疗原发性肺动脉高压的比较。
N Engl J Med. 1996 Feb 1;334(5):296-301. doi: 10.1056/NEJM199602013340504.
Zotero 插件